Seuraa
Richard Keefe
Richard Keefe
Professor of Psychiatry and Behavioral Sciences
Vahvistettu sähköpostiosoite verkkotunnuksessa duke.edu
Nimike
Viittaukset
Viittaukset
Vuosi
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
JA Lieberman, TS Stroup, JP McEvoy, MS Swartz, RA Rosenheck, ...
New England journal of medicine 353 (12), 1209-1223, 2005
74292005
The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity
KH Nuechterlein, MF Green, RS Kern, LE Baade, DM Barch, JD Cohen, ...
American Journal of Psychiatry 165 (2), 203-213, 2008
24182008
Persistent cannabis users show neuropsychological decline from childhood to midlife
MH Meier, A Caspi, A Ambler, HL Harrington, R Houts, RSE Keefe, ...
Proceedings of the National Academy of Sciences 109 (40), E2657-E2664, 2012
19652012
The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery
RSE Keefe, TE Goldberg, PD Harvey, JM Gold, MP Poe, L Coughenour
Schizophrenia research 68 (2-3), 283-297, 2004
16442004
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial
RSE Keefe, RM Bilder, SM Davis, PD Harvey, BW Palmer, JM Gold, ...
Archives of general psychiatry 64 (6), 633-647, 2007
14122007
Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment
JP McEvoy, JA Lieberman, TS Stroup, SM Davis, HY Meltzer, ...
American Journal of Psychiatry 163 (4), 600-610, 2006
12332006
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria
MF Green, KH Nuechterlein, JM Gold, DM Barch, J Cohen, S Essock, ...
Biological psychiatry 56 (5), 301-307, 2004
11422004
The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis
RSE Keefe, SG Silva, DO Perkins, JA Lieberman
Schizophrenia bulletin 25 (2), 201-222, 1999
10241999
Antipsychotic drug effects on brain morphology in first-episode psychosis
JA Lieberman, GD Tollefson, C Charles, R Zipursky, T Sharma, RS Kahn, ...
Archives of general psychiatry 62 (4), 361-370, 2005
9432005
Schizophrenia is a cognitive illness: time for a change in focus
RS Kahn, RSE Keefe
JAMA psychiatry 70 (10), 1107-1112, 2013
9242013
Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment
PD Harvey, RSE Keefe
American journal of psychiatry 158 (2), 176-184, 2001
8912001
The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization
RS Kern, KH Nuechterlein, MF Green, LE Baade, WS Fenton, JM Gold, ...
American Journal of Psychiatry 165 (2), 214-220, 2008
8052008
Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study
A Reichenberg, A Caspi, HL Harrington, R Houts, RSE Keefe, RM Murray, ...
American Journal of Psychiatry 167 (2), 160-169, 2010
6672010
Barriers to employment for people with schizophrenia
R Rosenheck, D Leslie, R Keefe, J McEvoy, M Swartz, D Perkins, ...
American Journal of Psychiatry 163 (3), 411-417, 2006
6632006
Cognitive impairment in schizophrenia
RSE Keefe, PD Harvey
Novel antischizophrenia treatments, 11-37, 2012
6302012
Baseline neurocognitive deficits in the CATIE schizophrenia trial
RSE Keefe, RM Bilder, PD Harvey, SM Davis, BW Palmer, JM Gold, ...
Neuropsychopharmacology 31 (9), 2033-2046, 2006
5902006
How Should DSM-V Criteria for Schizophrenia Include Cognitive Impairment?
RSE Keefe, WS Fenton
Schizophrenia bulletin 33 (4), 912-920, 2007
5872007
Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic
TS Stroup, JA Lieberman, JP McEvoy, MS Swartz, SM Davis, ...
American Journal of Psychiatry 163 (4), 611-622, 2006
5792006
A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia
RW Buchanan, M Davis, D Goff, MF Green, RSE Keefe, AC Leon, ...
Schizophrenia bulletin 31 (1), 5-19, 2005
5692005
A genome-wide investigation of SNPs and CNVs in schizophrenia
AC Need, D Ge, ME Weale, J Maia, S Feng, EL Heinzen, KV Shianna, ...
PLoS genetics 5 (2), e1000373, 2009
5592009
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20